Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers

NCT02108288 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: OPC-1085EL ophthalmic solution
DRUG: Carteolol long-acting ophthalmic solution
DRUG: Latanoprost ophthalmic solution

Sponsor

Otsuka Pharmaceutical Co., Ltd.